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Available online 12 March 2014Abstract Stem cells are attractive tools to develop new therapeutic strategies for a variety of disorders. While ethical and
technical issues, associated with embryonic, fetal and neural stem cells, limit the translation to clinical applications, the nasal
stem cells identified in the human olfactory mucosa stand as a promising candidate for stem cell-based therapies. Located in the
back of the nose, this multipotent stem cell type is readily accessible in humans, a feature that makes these cells highly suitable
for the development of autologous cell-based therapies. However, preclinical studies based on autologous transplantation
of rodent olfactory stem cells are impeded because of the narrow opening of the nasal cavity. In this study, we report the
development of a unique method permitting to quickly and safely biopsy olfactory mucosa in rats. Using this newly developed
technique, rat stem cells expressing the stem cell marker Nestin were successfully isolated without requiring the sacrifice of the
donor animal. As an evidence of the self-renewal capacity of the isolated cells, several millions of rat cells were amplified from a
single biopsy within four weeks. Using an olfactory discrimination test, we additionally showed that this novel biopsy method
does not affect the sense of smell and the learning and memory abilities of the operated animals. This study describes for the
first time a methodology allowing the derivation of rat nasal cells in a way that is suitable for studying the effects of autologous
transplantation of any cell type present in the olfactory mucosa in a wide variety of rat models.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).IntroductionThe use of stem cells for clinical applications represents a
scientific challenge prompting innovative strategies and⁎ Corresponding author at: Aix-Marseille Université, CNRS, UMR7259,
NICN, Centre St Charles, 3 place Victor Hugo, 13331 Marseille Cedex
03, France. Fax: +33 4 13 55 08 58.
E-mail address: francois.roman@univ-amu.fr (F.S. Roman).
http://dx.doi.org/10.1016/j.scr.2014.02.010
1873-5061/© 2014 The Authors. Published by Elsevier B.V. This is an open
licenses/by/3.0/).raising great hopes. To date, however, their use in clinic is
rather limited to a few applications. Even though some bone,
skin as well as corneal diseases or injuries can be treated with
grafting of related tissues for which the success relies on
stem cells present in the graft, hematopoietic stem cells
remain the only stem cell type routinely used in the clinic.
Indeed, hematopoietic stem cell transplantation allows for
the treatment of diseases and conditions of the blood and
immune system. Nevertheless, the plastic properties and the
self-renewal capacities characterizing a stem cell raise everaccess article under the CC BY license (http://creativecommons.org/
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strategies and have been proposed as a potential means of
treatment for a variety of disorders (Brignier and Gewirtz,
2010; George, 2010; Kim and de Vellis, 2009; Lawall et al.,
2010; Lindvall and Kokaia, 2006; Ronaghi et al., 2010).
Despite the accumulation of data in favor of the utilization
of stem cells and/or their derivatives, the translation from
the bench to the bedside remains difficult to achieve. Thus,
several problems such as ethical issues, cell availability,
graft rejection and the risk of tumor formation can poten-
tially be associated with their use (Boyd et al., 2012; Cantz
and Martin, 2010; Li et al., 2008; Somoza and Rubio, 2012),
which considerably curb their application to the clinic. Ac-
cordingly, the search for both stem cells and novel models of
study allowing to bypass these constraints could contribute
to speed up the long process leading to the development of
new stem cell-based strategies. Along this line, the develop-
ment of new methods involving autologous transplantations,
when applicable, would represent a major advantage for the
patients' safety and avoid several complications, placing this
kind of research as one of the priorities. Nevertheless, animal
models allowing the assessment of the effects induced by
autologous stem cell transplantations are limited and often
replaced by syngeneic transplantation instead.
Among the potential stem cell candidates for therapeutic
development, we have highlighted the existence of a promis-
ing multipotent contender residing within the nasal olfactory
mucosa (Delorme et al., 2010; Murrell et al., 2005; Tome et
al., 2009), a peripheral and permanently self-renewing ner-
vous tissue (Lindsay et al., 2010). This cell type has been
characterized as a member of the mesenchymal stem cell
superfamily displaying multilineage differentiation proper-
ties and a high proliferation rate in vitro (Delorme et al., 2010;
Murrell et al., 2005; Tome et al., 2009). Of note, we coined
the name “olfactory ecto-mesenchymal stem cells” (OE-MSCs)
to define this new stem cell type (Delorme et al., 2010).
Importantly, these cells present the advantage to be of ease
access in human (Girard et al., 2011), which support their
potential usefulness for autologous transplantation. In ro-
dents, OE-MSCs have been successfully used in different mod-
els includingmyocardial infarct (McDonald et al., 2010), spinal
cord trauma (Toft et al., 2012; Xiao et al., 2005, 2007), co-
chlear damage (Pandit et al., 2011) and Parkinson's disease
(Murrell et al., 2008) as well as in a mouse model that mimics
effects of ischemic/hypoxic injury in the hippocampus (Nivet
et al., 2011).
In the present study, we focused our attention on olfac-
tory lamina propria-derived stem cells. However, it can be
pointed out that this tissue also harbors another cell type of
great interest for the regenerative medicine, namely the
olfactory ensheathing cells (Feron et al., 2005; Mackay-Sim et
al., 2008).
Despite great promises raised by these different studies
and the use of stem cells and/or ensheathing cells for clinical
purposes, one major hurdle resides in the lack of a method
allowing the isolation of these cells in living animals for testing
the effects of autologous transplantations. Up to date, all data
that have been accumulated rely on the use of syngeneic
models (Bianco et al., 2004; Lu et al., 2001, 2002; McDonald et
al., 2010; Toft et al., 2012) or xenotransplantations of human
stem cells in rodent models (Murrell et al., 2008; Nivet et al.,
2011; Pandit et al., 2011; Xiao et al., 2005, 2007) requiring inmost cases the use of an immunosuppressant. Accordingly, the
establishment of a method to harvest stem or ensheathing
cells in an animal that could be at the same time the donor and
the receiver of its own cells may represent a major advance to
further test the full potential of these cells while excluding
complications/side effects associated to the use of alternative
methods of transplantation. While human olfactory mucosa is
readily accessible in humans, allowing autologous transplan-
tations, the narrow opening of the rodent nasal cavities can be
seen as an impassable hurdle, preventing the possibility of cell
autologous grafts in mice or rats. To overcome this problem,
we developed a unique technique of olfactorymucosa excision
allowing autologous grafts of nasal cells in rats. Biopsy col-
lection, rodent nasal stem cell characterization and amplifi-
cation as well as the consequence of the excision on the sense
of smell and cognitive abilities of the donor animals are re-
ported in this study.
Materials and methods
Rats
Ten-week-old male Sprague Dawley rats (n = 50; Charles
River), at the beginning of the experiment, were used. All
animals were housed in individual cages and maintained on a
12-hour light/12-hour dark cycle at a constant temperature
(22 +/− 1 °C). Food and water were provided ad libitum
except when tested for an olfactory associative discrimination
task. Anesthesia and surgical procedures were performed
according to the European law on Animal Care Guidelines,
and the Animal Care Committee of Aix-Marseille University
approved our protocols.
Excision of rat olfactory mucosa
Rat nasal olfactory mucosae were obtained by biopsies under
anesthesia (Sodium pentobarbital, Nembutal, 60 mg/kg, ip) and
under analgesia (buprenorphine hydrochloride, 0.03 mg/kg,
paracetamol 4 mg/kg, ip). In a first set of experiments
(n = 16), we tried to obtain pieces of olfactory mucosa by
creating a 2 mm long and 1 mm wide lateral aperture (right or
left) along the rostro-caudal axis, allowing a direct access to the
olfactory mucosa. Then, in order to improve the success rate,
we performed, in 34 rats, a 1 mm long and 2 mm wide medial
aperture (on top the septum), allowing an excision on both sides
of the nasal cavity (Fig. 1). More precisely, the head was first
inserted in a stereotactic frame. After resection of the tissues
covering the nasal and frontal bones at the level of the ocular
globes, the window was drilled in the skull just anterior to the
cribriform plate, 3.5 mm posterior to the nasofrontal suture
and 9 mm anterior to the bregma, according to the rat brain
atlas of Paxinos andWatson (2005). Using a “Hartmann Alligator
Micro-Forceps” (model MCO13B, Microfrance, Medtronic), a 1
square millimeter biopsy was excised. This piece of olfactory
mucosa was immediately transferred using a sterile needle into
a sterile 2 mL tube filled with 37 °C DMEM/HAM's F12 culture
medium (CM) supplementedwith 10% Fetal Bovine Serum (FBS),
100 units/mL of penicillin and 100 μg/mL of streptomycin (Life
Technologies). In order to exclude all risk of contamination,
antibiotic concentrations can be doubled at 200 units/mL of
penicillin and 200 μg/mL of streptomycin and 1.25 μg/mL of
Figure 1 Biopsy of olfactory mucosa in adult rat. Rat muzzle
drawings indicate the stereotaxic coordinates of the olfactory
mucosa excision. As shown from the midsagittal and the dorsal
views, the skull was drilled just anterior to the cribriform plate,
3.5 mm posterior to the nasofrontal suture and 9 mm anterior to
the bregma. The olfactory mucosa was excised using a Hartmann-
type micro-forceps.
Modified from Paxinos (2004) and Paxinos and Watson (2005).
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CM and maintained during the first week of culture. Then, the
tube was tipped upside down to make sure that the biopsy was
immersed in the culture medium.Isolation and expansion of stem cells
The biopsies were processed to isolate rat nasal stem cells
according to previously described methods with modifica-
tions (Feron et al., 2013; Girard et al., 2011). Two different
culture methods were assessed with the biopsies obtained
from lateral excisions (n = 16). For half of the group (n = 8),
the collected pieces of olfactory mucosa were washed in the
culture medium and immediately plated on 2 cm2 plastic
dishes. The other half of the biopsies was enzymatically and
mechanically dissociated. Briefly, after washing in the cul-
ture medium, the biopsies were immersed in 0.5 mL serum-
free culture medium containing 0.25% collagenase 1A (Life
Technologies), during 10 min at 37 °C. Dissociation of the
tissue was achieved by mechanical trituration, with the help
of a pipette, at three different times: at the start, in the
middle and at the end of the incubation period. Collagenaseactivity was inhibited by adding 5 mL of calcium-free and
magnesium-free PBS (Phosphate-Buffered Saline, Life Tech-
nologies). The tube was then centrifuged at 300 ×g, for
5 min. The cell pellet was resuspended in the previously
described culture medium (CM) and then plated on 2 cm2
plastic dishes. The culture medium was renewed every 2 to
3 days. About one week later, proliferation of rapidly divid-
ing cells was observed in the culture dish. When confluence
was reached, the cells were detached using a trypsin-EDTA
solution (0.05%, Life Technologies), centrifuged at 300 ×g,
for 5 min and replated in a dish with a two fold increased
surface area (i.e. 4 cm2) in the previously described culture
medium (CM). Similarly, at each passage, a 1:2 cell split ratio
was used. Then, the medial collection of biopsies from 34
supplementary rats was performed in the following chrono-
logical order. A group of 10 rats was halved and the two
above-described culture methods were assessed. Then, all
remaining biopsies (n = 24) were cultivated after enzymatic
and mechanic dissociations. A test on the effect of poly-L-
lysine coating was performed using 8 out of 24 biopsies. They
were cultivated into culture dishes pretreated or not with
poly-L-lysine, for at least 2 h, at the concentration of 5 μg/cm2
(Sigma-Aldrich). Since the poly-L-lysine coating provided a
more robust cell adhesion and proliferation, the culture of the
16 remaining biopsies was performed using this coating at
every passage.Generation of spheres
In order to generate stem cell spheres, trypsinized cells
were re-plated at a density of 30,000 cells/cm2 into culture
dishes pretreated with poly-L-lysine (5 μg/cm2) and fed with
serum-free DMEM/HAM'S F12 medium, supplemented with
insulin, transferrin, selenium (ITS-X, 1%, Life Technologies),
Epidermal Growth Factor (EGF, 50 ng/mL, R&D systems),
and Fibroblast Growth Factor 2, (FGF2, 50 ng/mL, R&D
systems). This culture medium was changed every other day.Immunostaining
Immunocytochemistry was carried out to analyze Nestin and
S100A4 expression. Cells were plated on glass coverslips at a
density of 15,000 cells/cm2 in the previously described culture
medium (CM) containing 10% FBS for 48 h. Cells were then
fixed, using a paraformaldehyde solution (4%, Antigenfix, MM
France) during 15 min, and incubated with a blocking solu-
tion (3% Bovine Serum Albumin and 0.1% Triton X-100 in PBS),
during 90 min at room temperature. The following primary
antibodies were used: mouse monoclonal anti-Nestin (1/250,
Abcys), rabbit monoclonal anti-S100A4 (1/200, Abcam). Cul-
tures were incubated with primary antibodies, diluted in the
blocking solution overnight at 4 °C, washed 3 times in PBS and
then incubated with the appropriate conjugated secondary
antibody, during 90 min, at room temperature in dark con-
ditions. The following secondary antibodies were used: goat
anti-mouse IgG conjugated with AlexaFluor 488 (1/500,
Jackson ImmunoResearch) and goat anti-rabbit IgG conjugated
with AlexaFluor 594 (1/500, Jackson ImmunoResearch). After
several washes in PBS, cultures were counterstained with
0.5 μg/mL Hoechst blue (33258, Sigma-Aldrich) for 30 min and
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Technologies).Olfactory associative discrimination task
Apparatus and training procedure
Three weeks post-surgery, the potential effect of the biopsy
on the sense of smell and on associative memory perfor-
mance of excised rats was tested using an olfactory
associative discrimination task developed in our laboratory
(Jacquet et al., 2013; Marchetti et al., 2008; Roman et al.,
1987). The olfactory training apparatus was a rectangular
box made of wire mesh (30 cm × 30 cm × 50 cm). A conical
odor port (1.5 cm in diameter, 0.5 cm above the floor) was
drilled horizontally through a triangular wedge of Plexiglas,
mounted in one corner of the cage. A circular (1 cm diam-
eter) water port in the shape of a well was placed directly
above the odor port. Responses to the odor presentation
were monitored by a photoelectric circuit. Two flashlight
bulbs which could be turned on and off when required by the
testing conditions, were placed outside the cage, one on
each side of the odor and water ports, 10 cm above the floor.
Individual odors were delivered by forcing clean air (0.7 bars)
through one of two 1 L Erlenmeyer flasks that contained
500 mL of water mixed with 0.2% of chemical odorants
(jasmine vs. strawberry) from Sigma Inc. Non-odorized air,
between each odor presentation, was delivered by sending
air through a flask that contained only water. Odorized and
clean air streams were passed individually through tubes
that were put through the back of the sound-attenuating
chamber and attached to the odor port. Water was delivered
using a gravity-fed system, and passed through a valve which,
when opened, allowed 0.1 mL of water to be released into
the water port.
All experiments were conducted simultaneously in four
olfactory cages to ensure that, in each experiment, repre-
sentatives from each group were trained at the same time,
and thus under identical conditions. Animals were trained to
make two odor-reward associations. Each odor had to be
associated with a specific reward, one arbitrarily designated
as positive and the other as negative. One session was made
of 60 trials using a successive “Go” or “No–Go” paradigm.
Individual trials (S+ or S−) were run in a quasi-random fashion
(no more than 3 consecutive trials with the same valence).
When the odor (S+) was delivered into the cage, if rat
responded by going to the water port a reward of 0.1 mL of
water was obtained. The same response to delivery of the
other odor (S−) resulted in no water and activation of an
error light. The maximum duration of odor presentation (S+
or S−) was 10 s. Correct responses, therefore, corresponded
to “Go” before the 10 second presentation for one odor had
elapsed (S+) and “No–Go” to the other (S−). After having
responded or not to the odor presentation (the trial), a fixed
inter-trial interval (ITI) of 15 s with clean air started. If a
response was given during the last second of the ITI, the next
trial was delayed by 10 s and delayed by additional 10 second
fractions as long as the rat was still present during the last
second of each fraction in the corner where the reward was
delivered. Consequently, the duration between two trials
lasted more than 15 s and constituted the cumulative time to
the minimum ITI. Animals were tested every day between08:00 am and 02:00 pm. Then, all animals were trained to
make associations with the odor pair for five sessions at a
pace of one session per day.
Data analysis
Correct responses were characterized as “Go” for the
positive odor and “No–Go” for the negative one. Incorrect
responses were “Go” for the negative odor and “No–Go” for
the positive one. The number of correct responses for both
positive and negative odors was expressed as a percentage of
the total number of odor presentations (60 per session),
thereby providing a global estimate of performance for all
groups (global memory). Training continued until a criterion
of 80 ± 5% correct responses was reached by the control
group, i.e. non-operated. This level of performance is re-
quired to ensure that all animals have learned both asso-
ciations. Latencies for positive (S+) and negative (S−) odors
were recorded and represented the time elapsed between
the beginning of a trial and its end (10 s), when the rat
responded to the odor (reference memory, which is pre-
sumed to correspond in some aspects to declarative memory
in humans). When a rat did not respond, a latency of 10 s was
scored. The median cumulative time (accounting for the
efficiency of some aspects of procedural memory) was the
number of seconds above the fixed 15 second ITI, divided by
the number of ITIs which, in this experiment, amounted 59.
All behavioral events were controlled and recorded by a
computer.
Statistical analysis
Statistical analyses were performed with SPSS/PC +statistics
11.0 software marketed by SPSS, Inc. All data are presented as
means ± SEM. Performance was analyzed using a repeated-
measure MANOVA. Then, subsequent ANOVAs for each session
were computedwhen necessary. The threshold for significance
was set at p ≤ 0.05.
Results and discussion
We first decided to evaluate the possibility to biopsy olfac-
tory mucosa in anesthetized adult rats in order to avoid
the sacrifice of the donor animal prior to harvest the tissue
of interest. To this end, we sought for a new methodology
involving the creation of a new route of access to the tissue.
Accordingly, we studied the rat anatomy and defined ste-
reotactic coordinates allowing the drilling of a hole that is
safe for the animal and provides an access to the olfactory
tissue. We found that a small opening of about 2 mm2 in the
frontal bone (see methods for the exact coordinates) was
sufficient to reach the olfactory mucosa located within the
posterior nasal cavity immediately anterior to the cribriform
plate (Fig. 1). Importantly, by introducing fine micro-forceps
through the drilled window, we demonstrated the possibility
to collect small pieces of olfactory mucosa. Noticeably,
biopsied animals were able to recover immediately after
the surgery without showing any signs of pain or distress
and none of them (n = 50) died after surgery. However only
the medial excision method (n = 34) provided a successful
and healthy culture of olfactory stem cells. When compared
with the technique using non-dissociated olfactory mucosa
(n = 5), the protocol based on enzymatic and mechanical
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cases, we observed morphological modifications of the
isolated cells, associated to an increased cell death and a
reduced proliferation rate. To avoid this phenomenon and
obtain a larger number of stem cells, the effect of a poly-
L-lysine coating was assessed on 8 others biopsies. We ob-
served that the use of poly-L-lysine, at every passage, had a
significant positive effect on the health and the proliferation
of these cultures. We also observed that cell plating density
should be over or equal to 50%, especially during the first
steps of amplification, to get a growing culture. With these
conditions, it is possible, in less than four weeks, to obtain a
stem cell population large enough to perform an autologous
graft. Once all culture conditions adjusted, the final exper-
iment was performed using 8 rats in which the olfactory
mucosa was collected using a medial aperture. The olfactory
cells were isolated by a dual enzymatic and mechanic disso-
ciation and cultivated in poly-L-lysine-coated dishes. Eight
rats (control group) underwent a sham operation without
biopsy excision.
To validate that the harvested tissue was the targeted
one, we evaluated whether it was possible to isolate stem
cells. Following a previously described procedure allowing
the isolation of rat olfactory stem cells (Girard et al., 2011),
we successfully derived cells exhibiting a mesenchymal stem
cell like morphology (Fig. 2A). As expected, cells were able
to generate spheres, when cultivated in the appropriate
culture conditions (Fig. 2B) and expressed Nestin, a protein
which is one of the most prominent hallmarks of stemness
(Fig. 2C). Moreover, purified rat cells were immuno-positive
for S100A4, a protein produced at high level in human nasal
olfactory stem cells (Fig. 2D), as previously reported (DelormeFigure 2 In vitro analysis of olfactory stem cells from adult rat olf
exhibit a mesenchymal morphology (A). Two key features of stem
(B and C). When grown in appropriate culture conditions, stem cells g
(in green, C). These cells also express a high level of S100A4, a mark
representative of three independent cultures from three different ret al., 2010). Human olfactory stem cells have been pre-
viously described as a highly proliferative cell type (Delorme
et al., 2010) and this characteristic was confirmed in our rat
cell cultures. Indeed, even though we established our cultures
from very small pieces of tissue, several millions of cells were
derived in less than a month time. We confirm here that rat
olfactory stem cells can be successfully amplified by suc-
cessive cell passages.
Our study being mainly focused on a new surgical
technique, we did not assess the purity of our olfactory
stem cell cultures. Nonetheless, we can rule out a putative
contamination with respiratory stem cells since the biopsy
was excised from the very posterior part of the nasal cavity
where only olfactory mucosa lies on the cartilage (Astic and
Saucier, 1986). It is more difficult to ascertain that other
contaminating cell types, especially ensheathing cells,
were not present in the dishes. It is however unlikely since
spheres were generated and all cells were immuno-positive
for Nestin and S100A4, two recognized markers for olfactory
lamina propria-derived stem cells (Delorme et al., 2010). In
addition, cells were grown up to passage 20 and no study has
so far reported that ensheathing cells exhibit such a high
proliferation ability and are able to generate spheres.
The self-renewal capacity of the peripheral olfactory
tissue (Chehrehasa et al., 2012; Graziadei and Metcalf, 1971;
Suzuki et al., 1998) and the limited size of the harvested
tissue (2 mm2) compared to the overall (675 mm2) surface of
olfactory mucosa (Gross et al., 1982) explain why the sense of
smell is not impaired. To confirm the non-deleterious effect
of biopsy excision on rat olfaction and learning/memory
capacities, we used an olfactory associative discrimination
task, three weeks after the surgery.actory mucosa. Stem cells, obtained with the reported method,
ness, sphere formation and Nestin expression, were evaluated
ive rise to spheres (B) and most of them highly expressed Nestin
er for human nasal olfactory stem cells (in red, D). Each image is
ats. Scale bars, 200 μm.
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showed that both excised and control groups improved
their overall performance similarly across the five sessions
(MANOVA, Group × Session interaction: [F(4,56) = 0.15, NS])
and the overall Group effect was not significant [F(1,14) =
0.14, NS]. The cumulative time (Fig. 3B) decreased across
sessions for both groups. The Group × Session interaction was
not significant [F(4,56) = 0.29, NS] and no significant differ-
ence was observed between these two groups along the five
successive sessions [F(1,14) = 0.41, NS]. Training performance
analyzed in terms of S+ and S− latencies (Fig. 3C) showed noA
B
C
Figure 3 Effect of the biopsy on the sense of smell and on
associative memory performance. Behavioral mean performance
(±SEM) obtained across five sessions of 60 trials in “Controls”
and excised rats (“olfactory biopsy”) (n = 8 for both groups).
(A) Mean percentage of correct responses for each session.
(B) Mean cumulative time (in seconds). (C) Mean latencies (in
seconds), S+ being the latencies for the positive odor and S− the
latencies for the negative odor. No significant statistical dif-
ference was observed between the two groups throughout the
successive five sessions, whatever the analyzed parameters.impairment on odor detection and memory performance
in the excised group. Indeed, similarly to the Controls, excised
rats were able to make correct associations on S+ and S−
stimuli. In the control group, correct associations were ob-
served from the fourth session onwards [F(1,15) ≥ 37.74;
p b 0.001] and the excised rats since the third session
[F(1,15) ≥ 8.11; p b 0.05]. The excised and the control groups
showed a continuous decrease in latencies of response to S+
stimuli throughout the training session while for S− stimuli a
decrease was observed during sessions 2 and 3, prior to
withhold their responses (and therefore, started to exhibit
correct behavior). Consequently, no significant difference
between groups was observed across sessions on S + [F(4,56) =
1.27; NS] and S− stimuli [F(4,56) = 0.66; NS]. These behav-
ioral results demonstrate that olfactory biopsies do not affect
the sense of smell since operated rats are able to keep
discriminating the odors, as demonstrated by their capacity to
learn and memorize odor-reward associations.
Conclusions
This unique technique developed in rats allows in less than
15 min to biopsy olfactory mucosa, without significant im-
pairment in odor discrimination. We show here that olfactory
stem cells can be expanded in vitro. It should however be
pointed out that the same technique can be used for cul-
tivating other olfactory cell types of interest, especially the
olfactory ensheathing cell. The latter can be easily ampli-
fied in culture, as demonstrated before (Bianco et al., 2004;
Richter et al., 2008). Overall, the currently reported pro-
tocol will allow experiments based on autologous grafting
of nasal olfactory cells, paving the way for clinical trials in
humans.
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